作者
Reinoud E. Knops,Michael S. Lloyd,Paul R. Roberts,David J. Wright,Lucas V.A. Boersma,Rahul N. Doshi,Paul A. Friedman,Petr Neužil,Carina Blomström‐Lundqvist,Maria Grazia Bongiorni,Martin C. Burke,Daniel Gras,Steven P. Kutalek,Anish K. Amin,Eugene Y. Fu,Laurence M. Epstein,José Marı́a Tolosana,Thomas Callahan,Johan D. Aasbo,Ralph Augostini,Harish Manyam,Devi G. Nair,Blandine Mondésert,Wilber Su,Chris Pepper,Marc A. Miller,Jon A. Grammes,Karim Saleh,Christelle Marquié,Faisal M. Merchant,Yong‐Mei Cha,Colin Cunnington,David S. Frankel,Julie West,Elizabeth Matznick,Bryan Swackhamer,Amy J. Brisben,Jonathan Weinstock,Kenneth M. Steín,Vivek Y. Reddy,Lluı́s Mont
摘要
The subcutaneous implantable cardioverter-defibrillator (ICD) is associated with fewer lead-related complications than a transvenous ICD; however, the subcutaneous ICD cannot provide bradycardia and antitachycardia pacing. Whether a modular pacing-defibrillator system comprising a leadless pacemaker in wireless communication with a subcutaneous ICD to provide antitachycardia and bradycardia pacing is safe remains unknown.